Accessed:
ChemSpider Search and share chemistrynav-icon

(2R,14R,25Z,28Z)-5,8,11-Trihydroxy-2-[(8Z,11Z,14Z)-8,11,14-icosatrienoyloxy]-14-[(9Z,12Z)-9,12-octadecadienoyloxy]-5,11-dioxido-17-oxo-4,6,10,12,16-pentaoxa-5λ~5~,11λ~5~-diphosphatetratriaco nta-25,28-dien-1-yl (8Z,11Z,14Z,17Z)-8,11,14,17-icosatetraenoate

Molecular formula:C85H144O17P2
Average mass:1500.018
Monoisotopic mass:1498.987876
ChemSpider ID:35032020
stereocenter-icon

3 of 5 defined stereocentres

double-bond-stereo-icon

Double-bond stereo

plus-iconless-iconStructural identifiers
  • Names down_Arrow
plus-iconless-iconNames and synonyms
Verified

(2R,14R,25Z,28Z)-5,8,11-Trihydroxy-2-[(8Z,11Z,14Z)-8,11,14-icosatrienoyloxy]-14-[(9Z,12Z)-9,12-octadecadienoyloxy]-5,11-dioxido-17-oxo-4,6,10,12,16-pentaoxa-5λ~5~,11λ~5~-diphosphatetratriaco nta-25,28-dien-1-yl (8Z,11Z,14Z,17Z)-8,11,14,17-icosatetraenoate

[ACD/IUPAC Name]

(2R,14R,25Z,28Z)-5,8,11-Trihydroxy-2-[(8Z,11Z,14Z)-8,11,14-icosatrienoyloxy]-14-[(9Z,12Z)-9,12-octadecadienoyloxy]-5,11-dioxido-17-oxo-4,6,10,12,16-pentaoxa-5λ~5~,11λ~5~-diphosphatetratriaco nta-25,28-dien-1-yl-(8Z,11Z,14Z,17Z)-8,11,14,17-icosatetraenoat

[German]

[ACD/IUPAC Name]

(8Z,11Z,14Z,17Z)-8,11,14,17-Icosatétraénoate de (2R,14R,25Z,28Z)-5,8,11-trihydroxy-2-[(8Z,11Z,14Z)-8,11,14-icosatrienoyloxy]-14-[(9Z,12Z)-9,12-octadecadienoyloxy]-17-oxo-5,11-dioxydo-4,6,10,12,16-pent aoxa-5λ~5~,11λ~5~-diphosphatétratriaconta-25,28-dién-1-yle

[French]

[ACD/IUPAC Name]

8,11,14,17-Eicosatetraenoic acid, (2R)-3-[[[3-[[[(2R)-2,3-bis[[(9Z,12Z)-1-oxo-9,12-octadecadien-1-yl]oxy]propoxy]hydroxyphosphinyl]oxy]-2-hydroxypropoxy]hydroxyphosphinyl]oxy]-2-[[(8Z,11Z,14Z)-1-oxo-8 ,11,14-eicosatrien-1-yl]oxy]propyl ester, (8Z,11Z,14Z,17Z)-

[ACD/Index Name]
Unverified

(2R)-2,3-bis[(9Z,12Z)-octadeca-9,12-dienoyloxy]propoxy(2-hydroxy-3-{[hydroxy(2R)-3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyloxy]-2-[(8Z,11Z,14Z)-icosa-8,11,14-trienoyloxy]propoxyphosphoryl]oxy}propoxy)phosphinic acid

1′-[1-Eicsoate

1′-[1-Eicsoatetraenoyl-2-homo-g-linolenoyl-sn-glycero-3-phospho],3′-[1,2-dilinoleoyl-rac-glycero-3-phospho]-glycerol

1′-[1-Eicsoatetraenoyl-2-homo-γ-linolenoyl-sn-glycero-3-phospho],3′-[1,2-dilinoleoyl-rac-glycero-3-phospho]-glycerol

1′-[1-Eicsoic acid

Cardiolipin(20:4/20:3/18:2/18:2)

Cardiolipin(20:4n3/20:3n6/18:2n6/18:2n6)

Cardiolipin(20:4w3/20:3w6/18:2w6/18:2w6)

Cardiolipin(76:11)

Cardiolipins(20:4/20:3/18:2/18:2)

Cardiolipins(20:4n3/20:3n6/18:2n6/18:2n6)

Cardiolipins(20:4w3/20:3w6/18:2w6/18:2w6)

Cardiolipins(76:11)

CL(1′-[20:4(8Z,11Z,14Z,17Z)/20:3(8Z,11Z,14Z)],3′-[18:2(9Z,12Z)/18:2(9Z,12Z)])

CL(20:4(8Z,11Z,14Z,17Z)/20:3(8Z,11Z,14Z)/18:2(9Z,12Z)/18:2(9Z,12Z))

CL(20:4/20:3/18:2/18:2)

CL(20:4n3/20:3n6/18:2n6/18:2n6)

CL(20:4w3/20:3w6/18:2w6/18:2w6)

CL(76:11)